What Factors Influence Motor Complications in Parkinson Disease?: A 10-Year Prospective Study

被引:41
作者
Garcia-Ruiz, Pedro J. [1 ]
del Val, Javier [1 ]
Mahillo Fernandez, Ignacio [2 ]
Herranz, Antonio [1 ]
机构
[1] Fdn Jimenez Diaz, Dept Neurol, E-28040 Madrid, Spain
[2] Fdn Jimenez Diaz, Dept Res & Epidemiol, E-28040 Madrid, Spain
关键词
Parkinson disease; motor complications; motor fluctuations; dyskinesias; gait freezing; prospective study; LEVODOPA THERAPY; DYSKINESIA; FLUCTUATIONS; EVOLUTION; 5-YEAR; ONSET; AGE;
D O I
10.1097/WNF.0b013e31823dec73
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The causes and mechanism behind motor complications in Parkinson disease (PD) are still a subject of debate. Several factors including age at onset, evolution in years, and initial medication can influence the onset and severity of motor complications in PD. We studied patients with recent diagnosis of PD who were followed up prospectively for 10 years. Analysis included the progression of these patients, as measured by the Unified Parkinson Disease Rating Scale scores and the presence of motor complications (motors fluctuations, dyskinesias, and gait freezing) over time. The patient group was studied as a whole and by subgroups classified according to age at onset, initial treatment, and sex. By the end of the first decade, most patients exhibited dyskinesias (91%), motor fluctuations (62%), and freezing of gait (68%). An association was found between several patients' characteristics and presence of motor complications by 5 years, though not after 10 years of follow up. The apparition of motor fluctuations was mainly related to initial treatment (odds ratio [OR], 3.87). The development of dyskinesias was linked to initial treatment (OR, 8.31), age at onset (OR, 0.90), and sex (OR, 12.87).
引用
收藏
页码:1 / 5
页数:5
相关论文
共 34 条
[1]   Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].
Ahlskog, JE ;
Muenter, MD .
MOVEMENT DISORDERS, 2001, 16 (03) :448-458
[2]   6 YEARS OF HIGH-LEVEL LEVODOPA THERAPY IN SEVERELY AKINETIC PARKINSONIAN PATIENTS [J].
BARBEAU, A .
ARCHIVES OF NEUROLOGY, 1976, 33 (05) :333-338
[3]  
Biglan KM, 2009, ARCH NEUROL-CHICAGO, V66, P563, DOI 10.1001/archneur.66.1.nct90001
[4]   Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment [J].
Chaudhuri, K. Ray ;
Schapira, Anthony H. V. .
LANCET NEUROLOGY, 2009, 8 (05) :464-474
[5]  
Fahn S, 2000, ANN NEUROL, V47, pS2
[6]  
Fahn S, 2004, NEW ENGL J MED, V351, P2498
[7]   Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial [J].
Holloway, R ;
Shoulson, I ;
Kieburtz, K ;
McDermott, M ;
Tariot, P ;
Kamp, C ;
Day, D ;
Shinaman, A ;
Fahn, S ;
Lang, A ;
Marek, K ;
Seibyl, J ;
Weiner, W ;
Welsh, M ;
Pahwa, R ;
Coe, S ;
Barclay, L ;
Sutherland, L ;
Hildebrand, K ;
Hubble, J ;
Weeks, C ;
LeWitt, P ;
Miyasaki, J ;
Duff, J ;
Sime, E ;
Suchowersky, O ;
Stacy, M ;
Kurth, M ;
Brewer, M ;
Harrigan, M ;
Russell, DS ;
Fussell, B ;
Ford, B ;
Dillon, S ;
Hammerstad, J ;
Stone, C ;
Riley, D ;
Rainey, P ;
Standaert, D ;
Tennis, M ;
Wooten, F ;
Rost-Ruffner, E ;
Factor, S ;
Brown, D ;
Jankovic, J ;
Atassi, F ;
Kurlan, R ;
Gardiner, I ;
Panisset, M ;
Amyot, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15) :1931-1938
[8]   WHAT FEATURES IMPROVE THE ACCURACY OF CLINICAL-DIAGNOSIS IN PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY [J].
HUGHES, AJ ;
BENSHLOMO, Y ;
DANIEL, SE ;
LEES, AJ .
NEUROLOGY, 1992, 42 (06) :1142-1146
[9]   Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD [J].
Katzenschlager, R. ;
Head, J. ;
Schrag, A. ;
Ben-Shlomo, Y. ;
Evans, A. ;
Lees, A. J. .
NEUROLOGY, 2008, 71 (07) :474-480
[10]  
KOLLER WC, 1992, NEUROLOGY, V42, P6